MedTrace Logo

MSCT Chest in Suspected COVID-19 Patients

NCT04492865 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2020-07-30

No results posted yet for this study

Summary

The present study aimed to evaluate the accuracy of MSCT chest in the detection of COVID-19 cases and to correlate its diagnostic performance with that of the clinical presentation and CBC indices; using RT-PCR assays as a gold standard.

Conditions

Interventions

DEVICE

MSCT

-Laboratory tests: All routine indicators of CBC are evaluated * Nasopharyngeal and oropharyngeal swabs are obtained from each patient to confirm the positivity to Covid-19 by performing RT-PCR to detect the viral RNA. * MSCT Chest images of all patients are evaluated by three radiologists with variable experiences in CT chest interpretation. The readers are blinded of the RT-PCR results and the CBC indices of the patients and they have access only to the epidemiological history, clinical symptoms, and signs. By consensus, the radiologists score the chest CT as positive or negative for COVID-19 viral pneumonia. When the chest CT is classified as positive, the main CT features are recorded as present or absent (ground-glass opacity, crazy paving, consolidation, nodules, air bronchogram, air trapping, halo sign, reversed halo sign, bronchial wall abnormalities, vascular enlargement, pleural effusion, and lymphadenopathy.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Abeer Ali, M D · Assiut University

  • Sara Hassanin, MD · Assiut University

  • Marwa Khairallah, M D · Assiut University

  • Dalia Kamal, M D · Assiut University

  • Walaa Ali, M D · Assiut University

  • Salwa Seif Eldein, PhD · Assiut University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-30
Primary Completion
2020-08-30
Completion
2020-10-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04492865 on ClinicalTrials.gov